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Blood is pumped into the cardiac muscle through arteries called the coronary arteries. Over time, the accumulation
of cholesterol, coagulation factors, and cells on the walls of these arteries causes the walls to thicken and lose their
elasticity, resulting in the development of atherosclerosis. When the blood supply of the heart is diminished by
atherosclerosis, it can be restored by bypass surgery, in which atherosclerosis-free vein and/or artery grafts taken
from another area of the body are used to replace the atherosclerotic vessels. These biological grafts used in
surgery differ in biochemical composition and long-term patency. Although the great saphenous vein (GSV) has
been the most popular graft material in revascularization for years, it has recently been superseded by the internal
mammarian artery (IMA), which has a lower incidence of recurrence of atherosclerosis. The aim of the present
review is briefly to address the structure of the cardiovascular system and blood vessels, and then, in the light
recent data, to present the biochemical compositions and individual advantages of the graft materials used to
restore an impaired blood supply to the heart.
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The cardiovascular system and the heart
The major component of the cardiovascular system is
the heart, a muscular structure that pumps blood into
two distinct circulatory systems, namely the pulmonary
circulation that carries blood to and from the lungs, and
the systemic circulation that transports blood to and
from all the tissues and organs of the body (Norman and
Litwack 1997; Skwarek et al. 2006; Aydin 2011). An
adult heart is about the size of a person’s clenched fist
and weighs about 280 to 340 g in men and 230 to 280 g
in women (Norman and Litwack 1997). The human
heart, which beats about 100,000 times a day, pumps
7000 to 8000 liters of blood to a blood vessel network of
96,560 kilometers in the process (Norman and Litwack
1997; About Arrhythmia [homepage on the Internet]
(2012)).
The human heart, divided into right and left parts lon-
gitudinally, is also separated into ventricles and atria.* Correspondence: saydin1@hotmail.com
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in any medium, provided the original work is pThe heart functions to pump the blood from the venous
system to the arterial system (Norman and Litwack
1997; Skwarek et al. 2006). The right part of the heart
receives deoxygenated blood from the peripheral tissues
through the venae cavae and pumps it into the pulmon-
ary artery and thence the pulmonary circulation. The left
part of the heart receives oxygenated blood via the pul-
monary veins and then distributes it to all the peripheral
tissues through the aorta (Skwarek et al. 2006; Elghobary
and Légaré 2010). While the heart is thus employed, the
coronary arteries can become constricted due to athero-
sclerosis and their blood supply is impaired (Elghobary
and Légaré 2010; Miller et al. 2010).
Although the fact that constriction of coronary arteries
due to atherosclerosis affects human health has been
known for at least 3000 years, as evidenced by ancient
Egyptian papyri, it has been less than 300 years since an-
gina pectoris was first associated with coronary artery
constriction and less than 100 years since the first clin-
ical myocardial infarction was diagnosed (Cullen et al.
2005). Atherosclerosis is characterized by the accumula-
tion of cholesterol, coagulation factors and cells on the
vessel wall, weakening the underlying tunica media layer,open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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ques, which bring about a series of complications
(Elghobary and Légaré 2010; Miller et al. 2010; Cullen
et al. 2005). These plaques cause the vessel walls to
thicken, whereby the lumen is narrowed, reducing the
blood flow. Although atherosclerosis can affect all arter-
ies, the most commonly injured vessels are the aorta and
the coronary and cerebral arteries (Cullen et al. 2005).
A heart with constricted vessels cannot function prop-
erly for long: its contraction starts to deteriorate, and
this condition needs to be remedied by coronary artery
bypass surgery. In this treatment, artery or vein graft
materials are used to restore the blood supply to the
myocardium, the area affected by atherosclerosis of the
coronary artery (Aydin 2011; Elghobary and Légaré
2010). The grafting in this operation is performed by
stopping the heart, a “cardiopulmonary bypass”; or, if the
grafting is carried out without stopping the heart, or off
pump, the procedure is called “beating heart technique”
(Skwarek et al. 2006; Creswell et al. 2005).
The aim of this review is briefly to address the struc-
tures of the blood vessels in general, and then to present
a comparison of the individual advantages of internal
mammarian artery (IMA) and great saphenous vein
(GSV) grafts, the materials most commonly used for by-
pass surgery, from biochemical and physiological aspects
in the light of recent data.
Blood vessels
The other components of the cardiovascular system are
the blood vessels (Skwarek et al. 2006; Aydin 2011;
Cullen et al. 2005). Although blood vessels differ in
some ways they display important similarities. The walls
of high-pressure vessels (e.g. subclavian arteries) are
thicker than those of the vessels that transport blood
under lower pressure (e.g. subclavian veins). While the
diameters of arteries become smaller at each branching,
the diameters of veins increase with each new addition.
Even though the wall structure of minor vessels such as
capillaries and venules is simpler, all vessel walls are
composed of three layers (Tennant and McGeachie
1990). Blood vessels are classified into six groups:Figure 1 The histological structure of blood vessels. Bloocd vessels are
media, and adventitia.arteries, arterioles, veins, venules, capillaries, and lymph-
atic vessels (Tennant and McGeachie 1990; Gartner and
Hiatt 1997; Lafleur et al. 2003). The structures of these
vessels will be addressed in general; individual groups of
vessels will not be described separately. However, the ves-
sels used for grafting in coronary artery bypass surgery will
be dealt with in detail where appropriate in later parts of
this review.
The structure of blood vessels
Blood vessel walls comprise three main strata, namely
the tunica intima, tunica media, and tunica adventitia
(Figure 1). These three strata are described below
(Tennant and McGeachie 1990).
Tunica intima (inner layer)
The innermost portion of the wall is a single-cell endo-
thelial layer attached to a basal lamina. Among other
products, endothelial cells secrete type II, IV and V
collagens, laminin, endothelin, nitric oxide, and von
Willebrand factor. The subendothelial layer comprises
the basal lamina and a loose, fibroelastic band of con-
nective tissue and occasional smooth muscle cells. Both
these layers are arranged longitudinally. The membrana
elastica interna is the outermost portion of the suben-
dothelial layer, where elastic fibers are concentrated
(Tennant and McGeachie 1990; Gartner and Hiatt 1997;
Lafleur et al. 2003).
Tunica media (middle layer)
This layer is composed of smooth muscle cells in a circu-
lar arrangement, arranged concentrically on a matrix con-
taining type III collagen with proteoglycans together with
elastic fibers and elastic membranes. This layer, which is
very well developed in arteries, is formed from extracellu-
lar matrix smooth muscle cells. Capillaries and postcapil-
lary venules have no tunica media layer (Tennant and
McGeachie 1990; Gartner and Hiatt 1997).
Tunica adventitia (outer layer)
The outermost layer is composed of collagen and elastic
fibrils. In the veins, it consists mainly of smooth muscle.composed of three layers, called (from the lumen outwards) intima,
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the membrana elastica externa. The adventitia is the
most prominent layer in vein walls (Tennant and
McGeachie 1990; Gartner and Hiatt 1997; Lafleur et al.
2003). It extends into the peripheral connective tissue.
The walls of large vessels are perfused by small blood
vessels, the vasa vasorum, within the adventitia; the ad-
ventitia and media layers are too thick to be supplied
with nutrients and oxygen by diffusion from the lumen.
These vessels are found in smaller numbers in the arter-
ies but are more numerous and can extend to the media
layer in the veins. The intima and the innermost part of
the media in veins contain no vasa vasorum. Similarly,
lymphatic capillaries are found only in the adventitia in
arteries, but can reach the media layer in veins (Tennant
and McGeachie 1990).
Smooth muscles in blood vessel walls are stimulated
by unmyelinated sympathetic nerves (vasomotor nerves),
which contain the vasoconstrictor norepinephrin. Cho-
linergic vasodilator nerves also supply the arteries in
skeletal muscle tissue. To effect contraction of the arterial
wall smooth muscle, norepinephrin must diffuse into the
media layer. Gap junctions between the smooth muscle
cells in the tunica media layer enable neurotransmitters to
be transported to the inner muscle cells. While there are
nerve endings in both the adventitia and media layers in
the veins, arteries in general are more richly supplied with
nerve cells (Gartner and Hiatt 1997).
Coronary artery bypass surgery graft materials
A coronary bypass operation is performed on about one
million individuals around the world per annum. Gor-
don Murray, who studied the suturing of mammarian,
axillary or carotid arteries on the diseased left anterior
descending (LAD) artery in 1953, was the first to show
the efficacy of arterial grafts in the coronary circulation
(Murray 1953). Four years later, Sidney Smith reported
that a segment of saphenous vein from the leg could be
used to create a direct bypass from the aorta to the myo-
cardium and could maintain coronary blood circulation
(Smith et al. 1957). Currently, arterial grafts, venous
grafts, and synthetic grafts are all used in coronary by-
pass surgery. Grafts are usually classified as autologous
and non-autologous. Non-autologous arterial (pig in-
ternal thoracic artery (ITA)) and non-autologous venous
(v. umbicalis, VSM homograft) grafts are used, but not
commonly, so they will not be addressed in this article.
Autologous arterial grafts used in coronary bypass sur-
gery include those from the arteria radialis (AR), arteria
gastroepiploica dextra (AGED), arteria epigastrica infer-
ior (AEI), a. splenica, a. ulnaris, a. subscapularis, gastric
sinistra, and a. circumflexa femoris lateralis (Tennant
and McGeachie 1990; Deppe et al. 2013). However, since
long-term patency is critical for aorta coronary bypassoperations, the LIMA and saphena, which have longer
patency, are the two most commonly used graft mate-
rials at present (Ferrari and von Segesser 2006). The pa-
tency rate for AR, for instance, is reported to be 98%
initially, but decreases to 90% after one year (Bleiziffer
et al. 2007; Erenturk 1997). When the post-operative ten-
year patency rates for the left ITA AR and VSM were
compared angiographically, they were reported to be
97.5% for the left ITA 91.6% for the AR, and 67.1% for the
VSM (Risteski et al. 2006). Therefore, the present study
will focus primarily on the left internal mammarian artery
(LIMA) and the greater saphenous vein (GSV).
Arteries
The diameters of the arteries that transport the blood to
the capillary beds decrease with increasing distance from
the heart. Two arteries branch out from the heart. One
is the truncus pulmonalis, which arises from the right
ventricle; the other is the aorta, arising from the left
ventricle. The aorta, which arises from the upper part of
the heart, then makes a turn to the left and descends
(Tennant and McGeachie 1990; Lafleur et al. 2003). The
internal mammarian artery is the major graft material in
heart surgery (Erenturk 1997).
Left internal mammarian artery (LIMA)
The left internal mammarian artery (LIMA) arises from
the early inferior part of the subclavian artery in the
medial segment of the anterior scalene muscle. Passing
between the clavicula and the first costal cartilage, it de-
scends to the thorax and proceeds along the lateral side
of the sternum (Tennant and McGeachie 1990; Gartner
and Hiatt 1997). Posteriorly, it is above the pleura and is
traversed by the phrenic nerve. It proceeds behind the
superior sixth costal cartilage between the intercostal
muscles. After it passes the third costal cartilage it
moves to the anterior side of the transversus thoracis
muscle and then bifurcates into the superior epigastric
and musculophrenic arteries at the sixth costal cartilage
(Tennant and McGeachie 1990; Gartner and Hiatt 1997;
Lafleur et al. 2003). A bypass of the LIMA to the LAD
artery is common (Erenturk 1997; Sabik et al. 2008). Use
of the left internal thoracic artery instead of the saphe-
nous vein in coronary artery bypass surgery was widely
accepted in angiographic studies during the 1980s
(Fukui et al. 2010). Similarly, the use of bilateral LIMA
as a graft material was reported to improve survival in
recurrent myocardial ischemia after coronary bypass
(Lytle et al. 1999). When the LIMA is used in coronary
artery bypass grafting operations, operative mortality is
reduced, except for mortality due to complications asso-
ciated with the operation (Dabel et al. 2003). A LIMA
bypass to the left descending coronary artery in particu-
lar has long-term patency rates. Also, when the LIMA
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the LAD artery, positive effects on long-term morbidity
and mortality were reported (Crouch et al. 1999). When
the GSV was used as the graft material, it was reported
to provide a higher flow capacity than the in situ LIMA
(Fichelle et al. 2010). Histologically, the LIMA contains
fewer smooth muscle cells and has a more elastic struc-
ture (Tennant and McGeachie 1990). Anastomosis of
the left ITA to the RIA in coronary bypass operations is
the preferred anastomosis (Fukui et al. 2010); it is ac-
cepted world-wide as the “gold standard”.
Radial artery
Conventional CABG surgery utilizes a combination of
arterial and venous grafts. However, the radial artery
(RA) as a coronary artery bypass graft has also grown
over recent years. Because endothelial function is pre-
served in RA grafts (Verma et al. 2004). The RA was ini-
tially used for coronary revascularization by Carpentier
and colleagues in 1971 (Carpentier et al. 1973). But,
2 years later, its use was abandoned because of an occlu-
sion rate that was greater than that observed in saphe-
nous vein grafts. In 1992, Acar and colleagues indicated
that the RA is a reasonable alternative to other types of
conduits to complement the LIMA (Acar et al. 1992).
RA use is safe in patients with moderate to severe left
ventricular dysfunction (Fazel et al. 2003) and in patients
over the age of 65 (Modine et al. 2002). Since RA grafts
have a capable of autoregulating its size to adapt to
the target coronary circulation, as was compared with
GSV grafts and left internal mammary artery graft
(Chong et al. 2006). Finally, heart surgeons should keep
in mind that the RA should be limited to grafting native
vessels with a high degree of stenosis (>70%) because of
graft sensitivity to competitive flow and its increased
propensity to spasm (Maniar et al. 2002).
Veins
The saphenous vein, used as the graft material in coron-
ary artery bypass operations, belongs to the group of
superficial veins (Tennant and McGeachie 1990). There
are two main superficial veins in the lower extremities,
the vena saphena magna and vena saphena parva. Since
they are located above the membranous superficial fascia
and not in the skeletal muscle, these superficial veins
lack supporting tissue (Gartner and Hiatt 1997; Lafleur
et al. 2003). The vena saphena magna originates from
the dorsal venous arch as the continuation of the v. mar-
ginalis medialis in the dorsal part of the foot. It passes
the anterior side of the malleoli, proceeds inside the calf,
and, after passing through the posteromedial segment of
the popliteal cavity, reaches the interior aspect of the
femur (Tennant and McGeachie 1990). Then it goes up-
wards and flows into the femoral vein in the fossa ovalisat the superficial inguinal level. The vena saphena magna is
connected to the deep venous system and the vena
saphena parva through the v. perforans. The branch that is
critically involved in the formation of varicose masses, and
flows into the vena saphena magna, is the posterior arch
vein (also known as the Leonardo vein), which drains three
Cockett’s perforator vein groups (Taggart et al. 2001).
Vena saphena magna graft
The distal or proximal saphenous vein is commonly used
for coronary artery bypass operations. The saphenous vein
is preferred in grafting because its femoral segment is lar-
ger and it has a thick surface. J. Kunlin was the first to use
the saphenous vein as the graft material in femoro-
popliteal bypass in different locations in 1950 (Kunlin et al.
1950). The quality, length, histological structure, and the
status of its endothelial cells all contribute to the usefulness
of the saphenous vein as a graft material (Crouch et al.
1999)]. The success of the saphenous vein as the graft ma-
terial in aorto-coronary bypass is reported to depend on
the presence of perivenous fat and lack of traumatic injury
(Erenturk 1997). It has also been noted that the adminis-
tration of papaverine to the peripheral tissues around the
saphenous vein increased its patency (Kocailik et al. 2008).
Venous grafts are used in a variety of locations. A femoro-
popliteal bypass can be used in the reverse direction, or in
the same direction after the valves are removed (Erenturk
1997; Alrawi et al. 2001). Furthermore, the great saphenous
vein or the small saphenous vein, as well as veins taken
from the arm, can be used as graft materials for vessels
around the tibia, ankle, and foot. The saphenous vein has
become indispensable as graft material for hepatic-renal,
iliorenal and aorto-coronary bypasses, when it is available
for use (Kelsall et al. 2005). It is also the graft material of
choice in cases of carotid narrowing where endarterectomy
is not possible (Norman and Litwack 1997). No-touch
techniques have been developed to remove the saphenous
vein with as little injury as possible. Uninjured saphenous
veins with a diameter of 5 mm taken from the tibial area
and including as few valves as possible are preferred as
high-quality graft materials (Kelsall et al. 2005; Plass et al.
2010). Studies evaluating the effects of neuropeptides
including substance P, vasoactive intestinal peptide, calci-
tonin gene-related peptide, neuropeptide Y and somato-
statin on the human saphenous vein showed many effects
on vascular tonus and these effects were endothelium-
dependent (Luu et al. 1992). Further studies are suggested
to explore how these effects can increase the performance
of graft materials in bypass operations.
Comparison of grafts in terms of biochemical
composition
Until two decades ago, the autogenous greater saphe-
nous vein (GSV) was the most popular graft material in
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ease, despite the common occurrence of atherosclerotic
events in the post-operative period. However, recent
studies have reported that, owing to its long-term pa-
tency or the late development of atherosclerotic lesions,
the internal mammary artery (IMA) could be the best
alternative for revascularization (Erenturk 1997; Sisto
et al. 1990). The later development of atherosclerotic le-
sions in the IMA than in the saphenous vein has been
attributed to the difference in biochemical compositions
of the two vessels (Table 1).
The endothelial cells of arteries have a greater capacity
to secrete endothelium-dependent relaxation factors
(EDRF) than those of veins. The main functions of EDRF
include endothelium-dependent relaxation, prevention
of vasospasms, and protection against intravascular
thrombus formation and atherogenesis. The endothe-
lium has the capacity to synthesize nitric oxide (NO),
prostacyclin (PGI2), endogenous vasoactive or inactive
products (angiotensin-1 and bradykinin), endothelin-1,
and endoperoxides (prostacyclin H2 and thromboxane
A2, which are constriction factors) (Kocailik et al. 2008).
The endothelium of the IMA spontaneously secretes
more NO than that of the GSV (Oku et al. 1990). NO, a
vasodilator inhibits thrombocyte adhesion and aggrega-
tion and is critical for maintaining the patency of the
vessel lumen (Kocailik et al. 2008). Furthermore, the
IMA contains more elastic lamina in its tunica mediaTable 1 Comparison of some biochemical compositions of
internal mammary artery and greater saphenous vein
grafts (Skwarek et al. 2006; Sisto et al. 1990; Hwang et al.
2012; Oku et al. 1990; Vanhoutte 1997); Aydin 2011;





Heparan sulfate High Low
Dermatan sulfate Low High
Esterified cholesterol High Low





Total GAG High Low
Hyaluronic acid High Low
Chondroitin
sulfate (A + B)*
High Low




*High, but not significant.than other arterial grafts or the GSV. The greater sensi-
tivity of the IMA than the GSV to vasoactive materials is
believed to be the reason for its better patency rate
(Erenturk 1997; Sisto et al. 1990).
Veins are more vulnerable than arteries to vasoactive
substances and cannot work under high pressure.
Additionally, while vein walls are supplied by vasa
vasorum, arterial walls are supplied by both the lumen
and vasa vasorum. Veins secrete vasoactive substances
in very different kinds and amounts from arteries
(Tennant and McGeachie 1990; Gartner and Hiatt 1997;
Lafleur et al. 2003). The peptides apelin and salusin, for
instance, are reported to be produced in larger quantities
in the aorta and LIMA than in the saphena. Salusins
suppress ventricular performance and exert inotropic
and chronotropic effects (Skwarek et al. 2006; Vanhoutte
1997; Aydin et al. 2012). It has been claimed that salusin
β influences cardiac output more strongly than other
well-known factors such as atrial natriuretic peptide or
NO (Kocailik et al. 2008). These substances, which are
produced in larger amounts in the arteries, could help to
explain why artery grafts last longer than saphenous
grafts. The major finding in support of this hypothesis is
that synthetic grafts, which lack these peptide hormones,
are less durable than biological grafts.
Biological grafts synthesize many substances including
cholesterol, hyaluronic acid, heparan sulfate, dermatan
sulfate, collagen, apelins and salusins (vasodilators). Col-
lagen is the main structural connective tissue protein in
blood vessels. The development of atherosclerosis leads
to an increase in the amount of collagens in the artery
walls. In the IMA, collagen constitutes between 25 and
40% of the total protein (Sisto et al. 1990). The fact that
coronary arteries contain more collagen than the IMA
suggests a predisposition to atherosclerosis. Of the
total protein in the saphenous veins, 65% is collagen,
which is much more than in arteries, another possible
reason why the IMA is advantageous over the saphena
(Sisto et al. 1990). Furthermore, the IMA contains less
free cholesterol than the saphena. Since less cholesterol
implies postponement of atherosclerosis, this could be
another advantage of using the IMA. Likewise, the
IMA contains more heparan sulfate than the saphena
(Erenturk 1997). As heparan sulfate is associated with
the bases of the cell membranes, arteries possess more
cellularity than veins. In contrast, there is more derma-
tan sulfate in GAGs in the saphena than the LIMA.
Since dermatan sulfate has a greater affinity for LDL and
VLDL than other GAG components, veins are more
predisposed to atherosclerosis than arteries (Sisto et al.
1990). Since the IMA secretes more prostacyclin
than the SVG, platelet adhesion and activation, and va-
sospasms, are prevented in the former, and the root
cause of atherosclerosis and graft occlusion is eliminated
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advantageous is that the diameter of this graft is compat-
ible with the diameters of the coronary arteries. Thus,
not only is turbulence eliminated, but also the incidence
of thrombus development is reduced (Skwarek et al.
2006; Vanhoutte 1997). In consideration of the differ-
ences in composition between these arteries and veins,
when biological grafts are going to be used for coronary
bypass surgery, care should be taken to avoid injury to
the endothelial layers of the vessels, where bioactive
materials are synthesized. Any disruption of this layer
will reduce the success of the graft. It is believed that if
the cells synthesizing bioactive hormones are totally
destroyed, the success rate of grafting will theoretically
fall to that of synthetic grafting (Skwarek et al. 2006).
From a histopathological perspective, intimal hyperpla-
sia, the first phase of atherosclerosis, is caused by
smooth muscle cells that pass through the defects in the
lamina elastica interna and invade the tunica intima.
Therefore, the lamina elastica interna plays a key role in
the artery wall structure, and its continuity along the
vessel wall forms a barrier preventing the invasion of
smooth muscle cells (Tennant and McGeachie 1990;
Gartner and Hiatt 1997; Lafleur et al. 2003). This feature
also makes the IMA advantageous over the GSV. How-
ever, pressure applied during harvesting of the saphe-
nous vein graft in coronary artery bypass surgery
decrease the patency (Ozturk et al. 2013).
In summary, currently most centers use the left in-
ternal thoracic (mammary) artery (LITA or LIMA). In
contrast to SV grafts, the IMA displays growth potential
in children with Kawasaki disease (Suda et al. 2000).
IMA also has atherosclerosis preventive effects on native
coronary artery which was grafted (Otsuka et al. 2013).
The anastomosed site stenosis with IMA had self-
healing potential and showed improved clinical out-
comes. Early adaptation of ITA after CABG within a few
weeks was also obtained. Arterial grafts are being in-
creasingly used in place of the SV to avoid the late com-
plications of vein graft atherosclerosis and restenosis.
(Otsuka et al. 2013).
Conclusion
Despite advances in technology and much hard work in
the field, it has not been possible to develop graft mate-
rials that can replace natural materials. Although vein
grafts are used commonly in coronary artery bypass sur-
gery, the ideal graft material is the autologous LIMA.
The ten-year patency rates range between 80 and 90%
for the IMA and 40 and 55% for the SVG (Erenturk
1997). The difference can be explained by the different
amounts of biochemical molecules in the grafts such as
cholesterol, collagen, and heparan sulfate, as well as the
histological compatibility and diameters of the vessels(Sisto et al. 1990; Hwang et al. 2012; Oku et al. 1990;
Vanhoutte 1997). This review presents the most recent
histological and biochemical data showing that IMA is
the best choice in coronary bypass surgery, and could
serve as a guide for heart surgeons.
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